Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Unsolved problems in haemophilia

L M Aledort1

  • 1Mount Sinai Medical Center, New York, NY, USA.

Haemophilia : the Official Journal of the World Federation of Hemophilia
|January 5, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The evolution of comprehensive haemophilia care in the United States: perspectives from the frontline.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Editorial Foreword.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Chairman's Introduction.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Chairman's Synthesis and closing remarks.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

Liver failure and mortality in HIV-positive haemophiliacs: FOURTEEN-YEAR EXPERIENCE AND LITERATURE REVIEW.

Haemophilia : the official journal of the World Federation of Hemophilia·2016
Same author

The EPIC study: a lesson to learn.

Haemophilia : the official journal of the World Federation of Hemophilia·2015

Hemophilia diagnosis and treatment remain inaccessible for most globally due to rising healthcare costs and inequities. Advanced therapies and preventative programs are out of reach for many patients with hemophilia.

Area of Science:

  • Hematology
  • Global Health Equity
  • Pharmacoeconomics

Background:

  • Hemophilia diagnosis and therapy are inaccessible for the majority of the global population.
  • Rising healthcare costs for hemophilia replacement products contribute to undertreatment.
  • Global health financing inequities exacerbate access issues for hemophilia patients.

Purpose of the Study:

  • To highlight the challenges in achieving adequate diagnosis and therapy for hemophilia patients worldwide.
  • To address the impact of rising healthcare costs on hemophilia management.
  • To discuss the implications of global health inequities on hemophilia care.

Main Methods:

  • Literature review on global hemophilia treatment access.
  • Analysis of healthcare financing models and their impact.

Related Experiment Videos

  • Examination of common complications like factor VIII inhibitors.

    • Main Results:

    • Most hemophiliacs worldwide lack access to diagnosis and therapy.
    • Factor VIII inhibitors, a common complication, are often undetected.
    • Preventative programs like prophylaxis and immune tolerance induction are not feasible for most patients.

    Conclusions:

    • Significant global challenges persist in providing essential hemophilia care.
    • Addressing healthcare costs and financing inequities is crucial for improving patient outcomes.
    • Developing accessible management strategies is essential for hemophiliacs globally.